Literature DB >> 8064727

Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.

H Endo1, T Hosono, H Kondo.   

Abstract

OBJECTIVE: To elucidate the distribution and frequency of antineutrophil cytoplasmic autoantibodies (ANCA) in systemic sclerosis.
METHODS: Patient sera were analyzed by indirect immunofluorescence and by enzyme linked immunosorbent assay.
RESULTS: High titers for perinuclear ANCA correlated with rapid deterioration of renal function. Patients were normotensive with normal plasma renin levels, but anemia, pulmonary hemorrhage and thrombocytopenia were problematic. All patients had anti-myeloperoxidase antibodies and some had anti-nRNP, anti-DNA, anti-Sm and LE cell antibodies. Outcome was poor except for one patient treated by plasmapheresis and cyclophosphamide.
CONCLUSION: A renal specific subset of systemic sclerosis is suggested.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064727

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.

Authors:  H Chikazawa; K Nishiya; A Matsumori; K Hashimoto
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

Review 2.  Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.

Authors:  P T Chan; C C Mok
Journal:  Clin Rheumatol       Date:  2012-05-30       Impact factor: 2.980

3.  A 66-Year-Old Woman With Hemoptysis.

Authors:  Falin B Patel; Kara S Couch; Sean McNish; Jonathan D Miller; Robert Siegel; Samantha Easley; Victoria K Shanmugam
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

4.  ANCA associated glomerulonephritis in a patient with mixed connective tissue disease.

Authors:  G Hernández-Molina; E Reyes; J C Crispín
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

5.  Antineutrophil cytoplasmic antibodies in systemic sclerosis.

Authors:  S Kiraz; H Simsek; I Ertenli; M Benekli; A Kadayifci
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

6.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-13       Impact factor: 2.631

7.  Systemic sclerosis and end-stage renal disease: study of patient characteristics, follow-up and outcomes in France.

Authors:  Aurélie Lavergne; Adelaïde Pladys; Cécile Couchoud; Mathilde Lassalle; Cécile Vigneau
Journal:  J Nephrol       Date:  2020-05-24       Impact factor: 3.902

8.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

9.  Microscopic polyangiitis in systemic sclerosis.

Authors:  Hiroshi Hashimoto
Journal:  Int J Rheumatol       Date:  2010-08-09

Review 10.  Antibodies in scleroderma: direct pathogenicity and phenotypic associations.

Authors:  Lorinda Chung; Paul J Utz
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.